MEDIKIT CO.,LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,892 JPY | -1.57% |
|
+1.65% | -0.31% |
| Sales 2022 | 20.13B 128M | Sales 2023 | 21.61B 138M | Capitalization | 41.01B 261M |
|---|---|---|---|---|---|
| Net income 2022 | 2.99B 19.07M | Net income 2023 | 2.86B 18.24M | EV / Sales 2022 | 0.55 x |
| Net cash position 2022 | 28.12B 179M | Net cash position 2023 | 27.59B 176M | EV / Sales 2023 | 0.62 x |
| P/E ratio 2022 |
13.1
x | P/E ratio 2023 |
14.3
x | Employees | 963 |
| Yield 2022 |
2.58% | Yield 2023 |
2.87% | Free-Float | 47.4% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.57% | ||
| 1 week | +1.65% | ||
| Current month | +1.65% | ||
| 1 month | +4.40% | ||
| 3 months | -6.26% | ||
| 6 months | +6.17% | ||
| Current year | -0.31% |
1 week
2 850.00
3 005.00
1 month
2 703.003 005.00
Current year
2 703.003 120.00
1 year
2 435.003 120.00
3 years
2 141.003 315.00
5 years
2 141.004 190.00
10 years
1 440.004 190.00
| Managers | Title | Age | Since |
|---|---|---|---|
Yoji Kageyama
PSD | President | 63 | 86-04-30 |
Takashi Nakajima
ADM | Chief Administrative Officer | 54 | 95-03-31 |
| Director/Board Member | 60 | 17-06-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Takashi Nakajima
ADM | Chief Administrative Officer | 54 | 95-03-31 |
Yoji Kageyama
PSD | President | 63 | 86-04-30 |
Yasuyuki Yoshida
BRD | Director/Board Member | 76 | 15-05-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-10 | 2,892 | -1.57% | 1 600 |
| 24-06-07 | 2,938 | -0.41% | 1,500 |
| 24-06-06 | 2,950 | +1.34% | 500 |
| 24-06-05 | 2,911 | -0.31% | 1,100 |
| 24-06-04 | 2,920 | +1.71% | 900 |
Delayed Quote Japan Exchange, June 10, 2024 at 01:57 am EDT
More quotes
MEDIKIT CO., LTD. is a Japan-based company involved in the development, manufacture and sale of medical equipment. Its major products consist of artificial diagnostic equipment, which includes indwelling needles that are used for artificial dialysis purposes; indwelling venous needles (anesthesia type), which are used for blood and fluid transfusion purposes, and angiography equipment, which includes introducers and angiographic catheters.
Calendar
2024-08-07
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -0.31% | 315M | |
| +75.69% | 12.57B | |
| +7.63% | 6.66B | |
| +15.10% | 5.5B | |
| -18.30% | 4.88B | |
| +14.96% | 4.1B | |
| -20.83% | 3.89B | |
| -27.11% | 2.83B | |
| +45.24% | 2.31B | |
| +1.98% | 2.07B |
- Stock Market
- Equities
- 7749 Stock
